Tested Applications
| Positive WB detected in | mouse brain tissue, MCF-7 cells, rat brain tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
55312-1-AP targets TBL1XR1 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | transducin (beta)-like 1 X-linked receptor 1 |
| Calculated Molecular Weight | 56 kDa |
| Observed Molecular Weight | 50-65 kDa |
| GenBank Accession Number | NM_024665 |
| Gene Symbol | TBL1XR1 |
| Gene ID (NCBI) | 79718 |
| RRID | AB_2881304 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9BZK7 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TBL1XR1 (also known as TBLR1) is an evolutionarily conserved F-box/WD40-repeat protein and an integral subunit of the NCoR/SMRT corepressor complexes. It functions as a molecular switch in transcriptional regulation, mediating both repression by unliganded nuclear receptors and activation via ubiquitin-proteasome-dependent corepressor exchange. TBL1XR1 is essential for Wnt/β-catenin and NF-κB signaling, and its mutations are associated with neurodevelopmental disorders and cancer (PMID: 26069883; 26769062; 14980219).
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for TBL1XR1 antibody 55312-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TBL1XR1 Polyclonal antibody (catalog #55312-1-AP) has 4 citations. They appear in Molecular Therapy–Nucleic Acids, Medical Oncology, Frontiers in Oncology, and Frontiers in Cardiovascular Medicine. Research fields include cervical cancer metastasis (via lncRNA upregulating TBL1XR1), early gastric cancer proteomics, liver circulating tumor cell survival, and atherosclerosis deterioration linked to macrophage-related genes. Applications documented include Western blotting (WB) and immunohistochemistry (IHC), studied in both human and mouse samples.
| Species | Application | Title |
|---|---|---|
Mol Ther Nucleic Acids Role of Long Noncoding RNA 799 in the Metastasis of Cervical Cancer through Upregulation of TBL1XR1 Expression. | ||
Med Oncol Data-independent acquisition (DIA) mass spectrometry reveals related proteins involved in the occurrence of early intestinal-type gastric cancer | ||
Front Oncol USP1 Maintains the Survival of Liver Circulating Tumor Cells by Deubiquitinating and Stabilizing TBLR1. | ||
Front Cardiovasc Med Macrophages-Related Genes Biomarkers in the Deterioration of Atherosclerosis. |



